C172H265N43O51
3751 g/mol
医药原料药警告
Liraglutide
利拉鲁肽
CAS204656-20-2
用途分类
医药原料药
化合物类别
多肽
主要用途
医药原料
Liraglutide is a pharmaceutical raw material used in the manufacturing of anti-diabetic medications. It is a synthetic peptide compound consisting of 33 amino acids with a fatty acid side chain, designed for use in research and production of treatments targeting type 2 diabetes and obesity.
active pharmaceutical ingredient for anti-diabetic formulationsresearch compound for metabolic disease studies
内容范围: 本页信息面向化学品识别与工业供应、研发、生产场景，不构成疗效宣称、医疗建议或药品使用指导。
正在采购或供应此化合物？
发布库存产品或采购需求
CAS 204656-20-2
相关化合物
强相关结构相似相似度 0.87
Glucagon-like peptide 1 (1-37)
CAS87805-34-3
医药原料
相似参考结构相似相似度 0.84
司美格鲁肽
CAS910463-68-2
医药原料
相似参考结构相似相似度 0.84
GLP-1 (1-36) amide (human, bovine, guinea pig, mouse, rat) trifluoroacetate salt H-His-Asp-Glu-Phe-Glu-Arg-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2 trifluoroacetate salt
CAS99658-04-5
医药原料
相似参考结构相似相似度 0.76
替度格魯肽
CAS197922-42-2
医药原料
参考同类别
Valerianol
CAS20489-45-6
医药原料
参考同类别
(R,R)-Epoxy Leucine Carfilzomib
CAS2049025-76-3
医药原料
参考同类别
Quinapyramine
CAS20493-41-8
医药原料
参考同类别
Upadacitinib hemihydrate
CAS2050057-56-0
医药原料
安全参考
警告
H351Suspected of causing cancer
H361Suspected of damaging fertility or the unborn child
标识符
IUPAC 名称
(2S)-5-[[(5S)-5-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-methylbutanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-methylpentanoyl]amino]-4-carboxybutanoyl]amino]acetyl]amino]-5-oxopentanoyl]amino]propanoyl]amino]propanoyl]amino]-6-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-carbamimidamido-1-[[2-[[(2S)-5-carbamimidamido-1-(carboxymethylamino)-1-oxopentan-2-yl]amino]-2-oxoethyl]amino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-4-carboxy-1-oxobutan-2-yl]amino]-6-oxohexyl]amino]-2-(hexadecanoylamino)-5-oxopentanoic acid
InChIKey
YSDQQAXHVYUZIW-QCIJIYAXSA-N
SMILES
CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)NCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)N)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC4=CC=C(C=C4)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](CC6=CN=CN6)N)C(=O)O
别名列表 (19)
- Liraglutida [INN-Spanish]
- Liraglutidum [INN-Latin]
- Liraglutida
- Liraglutide
- Liraglutide (rDNA origin)
- Liraglutide recombinant
- Liraglutidum
- NNC 90-1170
- Saxenda
- victoza